Descemet Endothelial Thickness Comparison Trial
Public ClinicalTrials.gov record NCT02373137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02373137
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Oregon Health and Science University
- Other
- Enrollment
- 38 participants
Conditions and interventions
Conditions
Interventions
- DSAEK Procedure
- DMEK Procedure
- Endoserter Device
- Prednisolone Drug
- Ofloxacin Drug
- Tropicamide Drug
- Phenylephrine Drug
- Jones Tube Device
Procedure · Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2015
- Primary completion
- Apr 3, 2018
- Completion
- May 29, 2023
- Last update posted
- Nov 24, 2020
2015 – 2023
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Byers Eye Institute, Stanford University | Palo Alto | California | 94303 | — |
| F. I. Proctor Foundation, University of California, San Francisco | San Francisco | California | 94143 | — |
| Casey Eye Institute, Oregon Health & Science University | Portland | Oregon | 97239 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02373137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02373137 live on ClinicalTrials.gov.